![The molecular rearrangement of carbon compounds. ^^^^^ ^Gl H 3 GH ^Cl 9Vz V CI. HgC /NlIHg ^1: GHg □3 =3° CH, H3C 3,CH,11; ^ H H^CLJCH^ 66 24 75 260 The molecular rearrangement of carbon compounds. ^^^^^ ^Gl H 3 GH ^Cl 9Vz V CI. HgC /NlIHg ^1: GHg □3 =3° CH, H3C 3,CH,11; ^ H H^CLJCH^ 66 24 75 260](https://c8.alamy.com/comp/2CEP316/the-molecular-rearrangement-of-carbon-compounds-gl-h-3-gh-cl-9vz-v-ci-hgc-nlihg-1-ghg-3-=3-ch-h3c-3ch11-h-hcljch-66-24-75-260-255-261-77-table-vii-continued-amine-sulphonylderivativein-p-b-pm-p-b-p-amine-2CEP316.jpg)
The molecular rearrangement of carbon compounds. ^^^^^ ^Gl H 3 GH ^Cl 9Vz V CI. HgC /NlIHg ^1: GHg □3 =3° CH, H3C 3,CH,11; ^ H H^CLJCH^ 66 24 75 260
![Table 1 from Derivation and validation of toxicophores for mutagenicity prediction. | Semantic Scholar Table 1 from Derivation and validation of toxicophores for mutagenicity prediction. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5adf0c58b96e6118cf5fb80dcab592cba25e8ff6/2-Table1-1.png)
Table 1 from Derivation and validation of toxicophores for mutagenicity prediction. | Semantic Scholar
![Antiproliferative and Erythroid Differentiation of Piperazine and Triphenyl Derivatives Against K-562 Human Chronic Myelogenous Leukemia | Anticancer Research Antiproliferative and Erythroid Differentiation of Piperazine and Triphenyl Derivatives Against K-562 Human Chronic Myelogenous Leukemia | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/33/8/3027/T1.medium.gif)